These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 35057713)
21. Depressive symptoms and chronic peripheral inflammation are associated with impaired functional remission in schizophrenia independently of psychotic remission. Fond G; Faugere M; Richieri R; Cermolacce M; Korchia T; Micoulaud-Franchi JA; Sunhary de Verville PL; Boyer L; Lançon C J Affect Disord; 2021 Feb; 280(Pt A):267-271. PubMed ID: 33220563 [TBL] [Abstract][Full Text] [Related]
22. Prevalence of and Risk Factors for Extrapyramidal Side Effects of Antipsychotics: Results From the National FACE-SZ Cohort. Misdrahi D; Tessier A; Daubigney A; Meissner WG; Schurhoff F; Boyer L; Godin O; Bulzacka E; Aouizerate B; Andrianarisoa M; Berna F; Capdevielle D; Chereau-Boudet I; D'Amato T; Dubertret C; Dubreucq J; Faget-Agius C; Lançon C; Mallet J; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Llorca PM; Fond G; J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30695288 [TBL] [Abstract][Full Text] [Related]
23. Motivational deficits in major depressive disorder: Cross-sectional and longitudinal relationships with functional impairment and subjective well-being. Fervaha G; Foussias G; Takeuchi H; Agid O; Remington G Compr Psychiatry; 2016 Apr; 66():31-8. PubMed ID: 26995233 [TBL] [Abstract][Full Text] [Related]
24. Inflammatory DEpression Advances in Schizophrenia (IDEAS): A precision medicine approach of the national FACE-SZ cohort. Fond G; Godin O; Schürhoff F; Berna F; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Dubertret C; Dubreucq J; Faget C; Leignier S; Lançon C; Mallet J; Marulaz L; Misdrahi D; Passerieux C; Rey R; Schandrin A; Urbach M; Vidailhet P; Leboyer M; ; Boyer L; Llorca PM J Affect Disord; 2019 Feb; 245():468-474. PubMed ID: 30428447 [TBL] [Abstract][Full Text] [Related]
25. Prospective Relationships Between Motivation and Functioning in Recovery After a First Episode of Schizophrenia. Fulford D; Piskulic D; Addington J; Kane JM; Schooler NR; Mueser KT Schizophr Bull; 2018 Feb; 44(2):369-377. PubMed ID: 28981811 [TBL] [Abstract][Full Text] [Related]
26. Mood symptoms, cognition, and everyday functioning: in major depression, bipolar disorder, and schizophrenia. Harvey PD Innov Clin Neurosci; 2011 Oct; 8(10):14-8. PubMed ID: 22132366 [TBL] [Abstract][Full Text] [Related]
27. A Group Intervention for Motivational Deficits: Preliminary Investigation of a Blended Care Approach Using Ambulatory Assessment. Thonon B; Levaux MN; van Aubel E; Larøi F Behav Modif; 2022 Sep; 46(5):1167-1197. PubMed ID: 34583549 [TBL] [Abstract][Full Text] [Related]
28. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health. Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171 [TBL] [Abstract][Full Text] [Related]
29. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia. Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465 [TBL] [Abstract][Full Text] [Related]
30. [What support of young presenting a first psychotic episode, when schooling is being challenged?]. Vacheron MN; Veyrat-Masson H; Wehbe E Encephale; 2017 Dec; 43(6):570-576. PubMed ID: 29128195 [TBL] [Abstract][Full Text] [Related]
31. Co-occurring depressive symptoms in the older patient with schizophrenia. Kasckow JW; Zisook S Drugs Aging; 2008; 25(8):631-47. PubMed ID: 18665657 [TBL] [Abstract][Full Text] [Related]
32. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for the Treatment of Schizophrenia and Related Disorders Aust N Z J Psychiatry; 2005; 39(1-2):1-30. PubMed ID: 15660702 [TBL] [Abstract][Full Text] [Related]
33. Exploring the correlates of suicide attempts among individuals with major depressive disorder: findings from the national epidemiologic survey on alcohol and related conditions. Bolton JM; Belik SL; Enns MW; Cox BJ; Sareen J J Clin Psychiatry; 2008 Jul; 69(7):1139-49. PubMed ID: 18517287 [TBL] [Abstract][Full Text] [Related]
34. Motivational deficits in early schizophrenia: prevalent, persistent, and key determinants of functional outcome. Fervaha G; Foussias G; Agid O; Remington G Schizophr Res; 2015 Aug; 166(1-3):9-16. PubMed ID: 25982811 [TBL] [Abstract][Full Text] [Related]
35. Predictors of medication adherence in a large 1-year prospective cohort of individuals with schizophrenia: insights from the multicentric FACE-SZ dataset. Misdrahi D; Dupuy M; Dansou Y; Boyer L; Berna F; Capdevielle D; Chereau I; Coulon N; D'Amato T; Dubertret C; Leignier S; Llorca PM; Lançon C; Mallet J; Passerieux C; Pignon B; Rey R; Schürhoff F; Swendsen J; Urbach M; Szöke A; Godin O; Fond G; Transl Psychiatry; 2023 Nov; 13(1):341. PubMed ID: 37935695 [TBL] [Abstract][Full Text] [Related]
36. Cognitive deficits in bipolar disorders: Implications for emotion. Lima IMM; Peckham AD; Johnson SL Clin Psychol Rev; 2018 Feb; 59():126-136. PubMed ID: 29195773 [TBL] [Abstract][Full Text] [Related]
37. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis. Demyttenaere K; Detraux J; Racagni G; Vansteelandt K CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941 [TBL] [Abstract][Full Text] [Related]
38. Letter to the Editor: Depression As The First Symptom Of Frontal Lobe Grade 2 Malignant Glioma. Nazlı ŞB; Sevindik M Turk Psikiyatri Derg; 2022; 33(2):143-145. PubMed ID: 35730515 [TBL] [Abstract][Full Text] [Related]
39. Chronic low-grade peripheral inflammation is associated with severe nicotine dependence in schizophrenia: results from the national multicentric FACE-SZ cohort. Fond G; Berna F; Andrianarisoa M; Godin O; Leboyer M; Brunel L; Aouizerate B; Capdevielle D; Chereau I; D'Amato T; Denizot H; Dubertret C; Dubreucq J; Faget C; Gabayet F; Llorca PM; Mallet J; Misdrahi D; Passerieux C; Richieri R; Rey R; Schandrin A; Urbach M; Vidailhet P; Boyer L; Schürhoff F; Eur Arch Psychiatry Clin Neurosci; 2017 Aug; 267(5):465-472. PubMed ID: 28238173 [TBL] [Abstract][Full Text] [Related]
40. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning. Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]